the effect of consumption of walnut inner shell on blood sugar and lipid profile of patients with diabetes
Phase 2
- Conditions
- Pharmacological treatment.
- Registration Number
- IRCT20121015011122N3
- Lead Sponsor
- Sanandaj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
Age over 18 years
Patients with type 2 diabetes have been diagnosed with diabetes for at least 3 months.
Patient cooperation
Completion of the informed consent form for participation in the research program by the participants
Do not take insulin
Take at least one oral antidiabetic medicine (metformin)
HbA1c=6.5% and FBS=126 mg / dl
Lack of special diet (except diabetic diet)
No chronic heart, kidney and liver failure
Do not use drugs and alcohol
It is good to have no mental illness and no physical condition
Exclusion Criteria
Patients taking insulin.
Patients with type 1 diabetes.
Patients with severe physical and mental conditions.
Patients who are allergic to walnuts.
Women who are pregnant or breastfeeding.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood sugar: The mean blood sugar in this study is the average fasting blood sugar of the patient. Timepoint: Before and after the intervention time. Method of measurement: Blood sample test.;Lipid profile: Lipid profile in this study is the average size of lipoproteins. Timepoint: Before and after the intervention time. Method of measurement: Blood sample test.;Glycosylated hemoglobin (HbA1c): A form of hemoglobin that is primarily used to measure the detection of moderate blood sugar levels over long periods of time. Timepoint: Before and after the intervention time. Method of measurement: Blood sample test.
- Secondary Outcome Measures
Name Time Method